101 related articles for article (PubMed ID: 8814840)
1. Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue.
Thomas SA; Brown IL; Hollins GW; Hocken A; Kirk D; King RJ; Leake RE
Br J Urol; 1996 Mar; 77(3):367-72. PubMed ID: 8814840
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
[TBL] [Abstract][Full Text] [Related]
4. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
Cardillo MR; Ippoliti F
Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of interlukin10 (IL10) and heat shock protein-90 (HSP-90) in prostatic carcinoma.
Bakir WA; Gaidan HA; Al-Kaabi MM
Indian J Pathol Microbiol; 2020; 63(2):230-234. PubMed ID: 32317521
[TBL] [Abstract][Full Text] [Related]
6. Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment.
Madersbacher S; Gröbl M; Kramer G; Dirnhofer S; Steiner GE; Marberger M
Prostate; 1998 Nov; 37(3):174-81. PubMed ID: 9792134
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of heat shock proteins, p63 and androgen receptor in benign prostatic hyperplasia and prostatic carcinoma in the dog.
Romanucci M; Frattone L; Ciccarelli A; Bongiovanni L; Malatesta D; Benazzi C; Brachelente C; Della Salda L
Vet Comp Oncol; 2016 Dec; 14(4):337-349. PubMed ID: 25059752
[TBL] [Abstract][Full Text] [Related]
9. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
Mohler JL; Chen Y; Hamil K; Hall SH; Cidlowski JA; Wilson EM; French FS; Sar M
Clin Cancer Res; 1996 May; 2(5):889-95. PubMed ID: 9816246
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry.
Deshmukh N; Scotson J; Dodson AR; Smith PH; Ke Y; Foster CS
Br J Urol; 1997 Dec; 80(6):869-74. PubMed ID: 9439399
[TBL] [Abstract][Full Text] [Related]
11. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo.
Tang D; Khaleque MA; Jones EL; Theriault JR; Li C; Wong WH; Stevenson MA; Calderwood SK
Cell Stress Chaperones; 2005; 10(1):46-58. PubMed ID: 15832947
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
Palmieri C; Mancini M; Benazzi C; Della Salda L
J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein expression in the eye and in uveal melanoma.
Missotten GS; Journée-de Korver JG; de Wolff-Rouendaal D; Keunen JE; Schlingemann RO; Jager MJ
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3059-65. PubMed ID: 12824252
[TBL] [Abstract][Full Text] [Related]
15. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
17. Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer.
Ratajczak W; Lubkowski M; Lubkowska A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055079
[TBL] [Abstract][Full Text] [Related]
18. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate.
Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C
J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552
[TBL] [Abstract][Full Text] [Related]
20. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution.
Maines MD; Abrahamsson PA
Urology; 1996 May; 47(5):727-33. PubMed ID: 8650873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]